Assetmark Inc. Sells 31,176 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Assetmark Inc. reduced its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 38.2% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 50,378 shares of the medical equipment provider’s stock after selling 31,176 shares during the quarter. Assetmark Inc.’s holdings in Intuitive Surgical were worth $26,295,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of the stock. State Street Corp grew its holdings in shares of Intuitive Surgical by 1.4% during the 3rd quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider’s stock worth $7,393,673,000 after purchasing an additional 210,363 shares in the last quarter. FMR LLC grew its holdings in shares of Intuitive Surgical by 8.3% during the 3rd quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock worth $5,389,765,000 after purchasing an additional 838,793 shares in the last quarter. Geode Capital Management LLC grew its holdings in shares of Intuitive Surgical by 1.9% during the 3rd quarter. Geode Capital Management LLC now owns 7,512,925 shares of the medical equipment provider’s stock worth $3,677,194,000 after purchasing an additional 143,440 shares in the last quarter. Fisher Asset Management LLC grew its holdings in shares of Intuitive Surgical by 1.8% during the 4th quarter. Fisher Asset Management LLC now owns 4,868,869 shares of the medical equipment provider’s stock worth $2,541,356,000 after purchasing an additional 86,488 shares in the last quarter. Finally, Baillie Gifford & Co. grew its holdings in shares of Intuitive Surgical by 0.6% during the 3rd quarter. Baillie Gifford & Co. now owns 3,848,547 shares of the medical equipment provider’s stock worth $1,890,676,000 after purchasing an additional 24,183 shares in the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on ISRG. Leerink Partners increased their target price on Intuitive Surgical from $490.00 to $548.00 in a report on Monday, January 27th. CICC Research assumed coverage on Intuitive Surgical in a research note on Monday, January 27th. They issued a “neutral” rating and a $550.00 price objective on the stock. Truist Financial raised their price objective on Intuitive Surgical from $640.00 to $666.00 and gave the company a “buy” rating in a research note on Friday, January 24th. Royal Bank of Canada raised their price objective on Intuitive Surgical from $611.00 to $641.00 in a research note on Monday, January 27th. Finally, UBS Group raised their price objective on Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a research note on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and sixteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $613.10.

Intuitive Surgical Price Performance

Shares of ISRG opened at $568.02 on Thursday. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00. The company has a market capitalization of $202.32 billion, a price-to-earnings ratio of 88.61, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43. The business has a 50-day moving average of $571.70 and a 200-day moving average of $530.90.

Insider Transactions at Intuitive Surgical

In other news, CFO Jamie Samath sold 270 shares of the firm’s stock in a transaction dated Tuesday, December 10th. The stock was sold at an average price of $540.15, for a total transaction of $145,840.50. Following the completion of the transaction, the chief financial officer now directly owns 8,757 shares in the company, valued at $4,730,093.55. This trade represents a 2.99 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Myriam Curet sold 408 shares of the firm’s stock in a transaction dated Tuesday, February 11th. The stock was sold at an average price of $589.75, for a total value of $240,618.00. Following the transaction, the executive vice president now owns 353 shares of the company’s stock, valued at $208,181.75. This trade represents a 53.61 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 12,598 shares of company stock worth $7,223,467 over the last ninety days. 0.90% of the stock is owned by insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.